CFG vs INBX · P/E 15, rev $2.28B vs rev $1.3M
Citizens Financial Group, Inc. (CFG) versus Inhibrx Biosciences, Inc. (INBX) — a side-by-side from cached financials, not a winner call.
Citizens Financial Group, Inc. (CFG) is a banks - regional company listed on US.
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
Latest reported CFG revenue for 2026-06-30 was $2.28B. Net income was $587.0M. Revenue was up 5.3% from 2026-03-31 to 2026-06-30. CFG currently screens at market cap $20.67B and trailing P/E 15.1.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
CFG currently screens at market cap $20.67B and trailing P/E 15.1. INBX currently screens at market cap $1.28B.
Not investment advice. Open the CFG and INBX stock pages for the full models.
Not investment advice.